This is a recording of the webinar held on August 23, 2023.
You've heard a LOT about semaglutide (e.g. Ozempic, Wegovy)/GLP-1 medications in both diabetes care and for intentional weight loss.
Are you clients/patients/communities asking questions about this class of medications?
Are you looking for more support in how to navigate these conversations with them, honoring body autonomy, informed consent, and your weight-inclusive approach?
The webinar panel features Dr. Erin Knopf CEDS, Lauren Newman RD CDCES CEDS, Erin Ebert LCSW, and Dr. Rebecca Berens MD. Moderated by Heather Caplan RDN.
Participants will be able to:
Describe mechanisms of these medications, including intended uses, doses, side effects, etc.
Understand current literature on the usage of these medications for both diabetes management and weight loss.
Use the information to guide their patient education and medical nutrition therapy counseling in a variety of client and patient populations.
*pending CPEU approval for replay activity type
weightinclusivenutrition.com
